in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cost Pressure Continues
11:37 AM MST | December 9, 2011 | —Deepti Ramesh
Active pharmaceutical ingredient (API) manufacturers around the world continue to be squeezed by rising costs, and pressure from customers in the pharmaceutical industry seeking lower raw material prices. “The cost pressure on API manufacturing is intense,” says Stefan Stoffel, head of chemical manufacturing at Lonza. “This is why Lonza has put a tremendous amount of work into developing an efficient sourcing organization, lean and innovative processes, and operational excellence initiatives.” “Pharmaceutical companies are facing a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee